A Phase 1/2 Trial of Brief Androgen Suppression and Stereotactic Radiation Therapy (FASTR) for High-Risk Prostate Cancer - Concepedia

Concepedia

Publication | Closed Access

A Phase 1/2 Trial of Brief Androgen Suppression and Stereotactic Radiation Therapy (FASTR) for High-Risk Prostate Cancer

73

Citations

50

References

2015

Year

Glenn Bauman, Michelle Ferguson, Michael Lock, Jeff Chen, Belal Ahmad, V. Venkatesan, Tracy Sexton, David D’Souza, Andrew Loblaw, Andrew Warner,

International Journal of Radiation Oncology*Biology*Physics

Phase 1/2UrologyRadiation MedicineHigh-risk Prostate CancerRadiation TherapyMedicineBrief Androgen SuppressionProstatic DiseaseOncologyRadiation Oncology

References

	Year	Citations

Page 1

Page 1